This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
secondary antibody
product name :
HUMAN IgG1 KAPPA
catalog :
PHP010
quantity :
1 mg
citations: 10
Reference
Huh J, White A, Brych S, Franey H, Matsumura M. The identification of free cysteine residues within antibodies and a potential role for free cysteine residues in covalent aggregation because of agitation stress. J Pharm Sci. 2013;102:1701-1711 pubmed publisher
Rosental B, Brusilovsky M, Hadad U, Oz D, Appel M, Afergan F, et al. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J Immunol. 2011;187:5693-702 pubmed publisher
Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks D, et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol. 2012;69:198-207 pubmed publisher
Bohrmann B, Baumann K, Benz J, Gerber F, Huber W, Knoflach F, et al. Gantenerumab: a novel human anti-A? antibody demonstrates sustained cerebral amyloid-? binding and elicits cell-mediated removal of human amyloid-?. J Alzheimers Dis. 2012;28:49-69 pubmed publisher
Hershkovitz O, Rosental B, Rosenberg L, Navarro Sanchez M, Jivov S, Zilka A, et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol. 2009;183:2610-21 pubmed publisher
Rosano J, Tousi N, Scott R, Krynska B, Rizzo V, PRABHAKARPANDIAN B, et al. A physiologically realistic in vitro model of microvascular networks. Biomed Microdevices. 2009;11:1051-7 pubmed publisher
Arnon T, Markel G, Bar Ilan A, Hanna J, Fima E, Benchetrit F, et al. Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy. PLoS ONE. 2008;3:e2150 pubmed publisher
Hershkovitz O, Jivov S, Bloushtain N, Zilka A, Landau G, Bar Ilan A, et al. Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry. 2007;46:7426-36 pubmed
Campbell S, Burkly L, Gao H, Berman J, Su L, Browning B, et al. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol. 2006;176:1889-98 pubmed
Zilka A, Landau G, Hershkovitz O, Bloushtain N, Bar Ilan A, Benchetrit F, et al. Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46. Biochemistry. 2005;44:14477-85 pubmed
product information
Entity Category :
Antigens and Lysates
Region :
KAPPA
Product Code :
PHP010
Description :
HUMAN IgG1 KAPPA
Specificity :
IgG1
Target Species :
Human
Format :
Purified
Applications :
E, FN*
Application Types :
ELISA, Functional Assays
Quantity :
1 mg
Quantity Value :
1 mg
Quantity Type :
mg
GO Accessions :
GO:0005515, GO:0003823, GO:0005576, GO:0006958, GO:0045087, GO:0005515, GO:0003823, GO:0005576, GO:0005624, GO:0006955
GO Terms :
alpha-2 macroglobulin receptor-associated protein activity, antibody, B cell receptor activity, complement cascade, classical pathway, extracellular, GO:0002226, GO:0045308, immunoglobulin, nonspecific immune response, opsonin activity, protein amino acid binding, protein degradation tagging activity, protein folding chaperone, protein tagging activity
Uniprot Accessions :
P01834, P01857
Gene :
IGHG1, IGKC
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3500, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3514
EntityFormats :
Purified
UNSPSC :
12352202
Concentration :
1.0 mg/ml
Product Form :
Purified protein - liquid
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.